-
Jubilant Pharmo Standalone September 2025 Net Sales at Rs 66.40 crore, down 59.93% Y-o-Y
-
Jubilant Pharmo Consolidated September 2025 Net Sales at Rs 1,966.40 crore, up 12.22% Y-o-Y
-
Jubilant Pharmo Consolidated June 2025 Net Sales at Rs 1,900.70 crore, up 9.76% Y-o-Y
-
Jubilant Pharmo Standalone June 2025 Net Sales at Rs 59.50 crore, down 64.31% Y-o-Y
-
Trade Spotlight: How should you trade Sumitomo Chemical, Prestige Estates, Kalyan Jewellers, Sharda Cropchem, Godfrey Phillips and others on July 21?
The consolidation is expected to continue until the Nifty 50 delivers a strong close above the midline of the Bollinger Bands. Below are some short-term trading ideas to consider.
-
Stocks to Watch Today: ITC, Bajaj Finance, Sun Pharmaceutical, Syngene, Natco Pharma, Vedanta, Sacheerome in focus on 16 June
Stocks to watch, 16 June: Gujarat Themis Biosyn, Godrej Properties, Sun Pharmaceutical Industries, Belrise Industries, Syngene International, Natco Pharma, Vedanta, ITC, Eicher Motors, South Indian Bank, NTPC, Nazara Technologies, Scoda Tubes, Shalby, Jubilant Pharmova, Jubilant Foodworks, and Jubilant Ingrevia will be in focus on June 16.
-
Jubilant Pharmo Consolidated March 2025 Net Sales at Rs 1,928.80 crore, up 9.68% Y-o-Y
-
Jubilant Pharmo Standalone March 2025 Net Sales at Rs 217.30 crore, up 5.59% Y-o-Y
-
Trade Spotlight: How should you trade Divis Labs, APL Apollo Tubes, UPL, GMR Airports, Jubilant Pharmova, Ceat and others on April 25?
The key indices are likely to consolidate and remain range-bound in the upcoming sessions. Below are some trading ideas for the near term.
-
Stock Market Update: BEL, NTPC Green, Jubilant & More in Focus | March 13
Stay updated on the latest stock market movements! Bharat Electronics secures a ₹2,463 crore defense contract, NTPC Green commissions the final phase of its Shajapur Solar Project, and Jubilant Pharmova gets a key USFDA update. Plus, major developments from Satin Creditcare, BEML, and Zydus Lifesciences. Watch now for all the key highlights!
-
Stocks to Watch Today: Infosys, BEML, Jubilant Pharmova, Bharat Electronics, NACL Industries, Yatra Online, Swelect Energy Systems in focus on 13 March
Stocks to Watch, Mar 13: Stocks like Tata Steel, NHPC, NTPC Green Energy, Firstsource Solutions, Coromandel International, SP Apparels, Zydus Lifesciences, Jaiprakash Associates, Rollatainers, Satin Creditcare Network, and Ola Electric Mobility will be in focus on March 13.
-
Jubilant Pharmova Consolidated December 2024 Net Sales at Rs 1,821.70 crore, up 8.62% Y-o-Y
-
Jubilant Pharmo Standalone December 2024 Net Sales at Rs 196.00 crore, up 11.87% Y-o-Y
-
Stocks to Watch Today: Reliance Industries, Infosys, Axis Bank, LTIMindtree, Havells, HFCL, AstraZeneca, Jubilant Pharmova, Zaggle in focus on 17 January
Stocks To Watch, Jan 17: Stocks like Hatsun Agro Products, Metro Brands, Bharat Petroleum Corporation, Mastek, One Mobikwik Systems, Jammu & Kashmir Bank, Satin Creditcare Network, IRCTC, Power Finance Corporation, Suraksha Diagnostic, Indian Bank, TVS Motor Company, and Bajaj Healthcare will be in focus on January 17.
-
Jubilant Pharmo Consolidated September 2024 Net Sales at Rs 1,752.30 crore, up 4.28% Y-o-Y
-
Jubilant Pharmo Standalone September 2024 Net Sales at Rs 165.70 crore, down 11.06% Y-o-Y
-
Stock Radar: ITC, IndusInd Bank, NTPC, Oracle Financial, Shriram Properties, IXIGO, Dixon Tech, Cyient in focus on Friday
Stocks like Godrej Consumer Products, Indian Energy Exchange, United Breweries, JSW Energy, PNB Housing Finance, Mahanagar Gas, Chalet Hotels, CIE Automotive India, Petronet LNG, and Nippon Life India Asset Management will also be in focus on October 25.
-
Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday
IDFC First Bank, Dr Reddy’s Laboratories, Punjab National Bank, ICICI Prudential Life Insurance Company, Bharat Electronics, Tata Chemicals, Adani Enterprises, and Adani Energy Solutions will also be in focus on September 30.
-
Jubilant Pharmova stock in focus after US FDA's 'Voluntary Action Indicated' status for Spokane facility
USFDA determines inspection classification of ‘Voluntary Action Indicated’ for Jubliant Pharmova's contract manufacturing facility in USA.
-
Jubilant Pharmova zooms 9% to record high on heavy volumes
Trading volumes for Jubilant Pharmova were nine times higher as compared to average volume at this time of the day.
-
Jubilant Pharmova to invest in MNC Pierre Fabre’s French R&D centre via new unit
The French R&D centre has capability of conducting discovery and early development in immune-oncology.
-
Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday
UltraTech Cement, Maruti Suzuki India, Sun Pharma Advanced Research Company, Glenmark Life Sciences, Hindustan Zinc, Godawari Power and Ispat, Manappuram Finance, Jubilant Pharmova, and Strides Pharma Science will also be in focus on Monday.
-
Jubilant Pharmo Consolidated June 2024 Net Sales at Rs 1,731.70 crore, up 9.12% Y-o-Y
-
Jubilant Pharmo Standalone June 2024 Net Sales at Rs 166.70 crore, down 23.32% Y-o-Y
-
Jubilant Pharmova shares fall after USFDA classifies Canada facility as VAI
Jubilant Pharmova share price | The share touched a 52-week high of Rs 799.95 and a 52-week low of Rs 319.30 on 19 July, 2024 and 26 October, 2023, respectively.
